vatalanib has been researched along with paclitaxel in 2 studies
Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
276 | 42 | 98 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiorean, EG; Hall, SD; Jones, DR; Malireddy, S; Schneider, B; Sloop, MI; Sweeney, CJ; Waddell, MJ; Younger, AE; Yu, M | 1 |
Åhgren, A; Hasumi, Y; Heldin, CH; Hellberg, C; Kłosowska-Wardęga, A | 1 |
1 trial(s) available for vatalanib and paclitaxel
Article | Year |
---|---|
A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Paclitaxel; Phthalazines; Pyridines; Transaminases; Treatment Outcome | 2010 |
1 other study(ies) available for vatalanib and paclitaxel
Article | Year |
---|---|
Combination therapy using imatinib and vatalanib improves the therapeutic efficiency of paclitaxel towards a mouse melanoma tumor.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Becaplermin; Benzamides; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Imatinib Mesylate; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Phthalazines; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Proto-Oncogene Proteins c-sis; Pyridines; Pyrimidines; RNA, Small Interfering; Signal Transduction | 2011 |